Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential

Clinical and Experimental Metastasis

Volumn 17, Issue 6, 1999, Pages 463-469

  Capon, François ^a   Emonard, Hervé ^b   Hornebeck, William ^b   Maquart, François Xavier ^b   Bernard, Philippe ^a,c  

^a Lab d'Immunol et d'Hematologie   (France)

^b IFR 53 Biomolécules   (France)

^c NONE   (France)

Author keywords

Matrix metalloproteinases; Melanoma cells; Tumor invasion

Indexed keywords

COLLAGENASE; GELATINASE; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL INVASION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; PROTEIN EXPRESSION;

BLOTTING, NORTHERN; ENZYME ACTIVATION; ENZYME PRECURSORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MELANOMA; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0033511287     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006674709232     Document Type: Article

References (41)

1. 1. Hokha R, Denhardt DT. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invas Metast 1989; 9: 391-405.
2. 2. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-73.
3. 3. Vassalli JD, Pepper MS. Tumour biology. Membrane proteases in focus. Nature 1994; 370: 14-5.
4. 4. Chen WT. Proteases associated with invadopodia, and their role in degradation of extracellular matrix, Enzyme Protein 1996; 49: 59-71.
5. 5. Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP. Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases, Cancer Res 1990; 50: 97-6001.
6. 6. Edwards DR, Murphy G. Cancer. Proteases invasion and more. Nature 1998; 394: 527-8.
7. 7. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3: 895-904.
8. 8. Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993; 24: 209-18.
9. 9. Collier IE, Wilhelm SM, Eisen AZ et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1998; 263: 6579-87.
10. 10. Wilhelm SM, Collier IE, Marmer BL et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-21.
11. 11. Emonard H, Remacle AG, Noël AC et al. Tumor cell surface-associated binding site for the Mr 72,000 type IV collagenase. Cancer Res 1992; 52: 5845-8.
12. 12. Toth M, Gervasi DC, Fridman R. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res 1997; 57: 3159-67.
13. 13. Brooks PC, Strömblad S, Sanders LC et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996; 85: 683-93.
14. 14. Menashi S, Dehem M, Souliac I et al. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells. Int J Cancer 1998; 75: 259-65.
15. 15. Olson MW, Toth M, Gervasi DC et al. High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. J Biol Chem 1998; 273: 10672-81.
16. 16. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 61-5.
17. 17. Strongin AY, Collier IE, Bannikov GA et al. Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331-8.
18. 18. Zucker S, Drews M, Conner C et al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MTI-MMP). J Biol Chem 1998; 273: 1216-22.
19. 19. Butler GS, Butler MJ, Atkinson SJ et al. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998; 273: 871-80.
20. 20. Kinoshita T, Sato H, Okada A et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998; 273: 16098-103.
21. 21. Seltzer JL, Lee AY, Akers KT et al. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 1994; 213: 365-74.
22. 22. Tomasek JJ, Halliday NL, Updike DL et al. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 1997; 272: 7482-7487.
23. 23. Jacubovich R, Doré JF. Tumor-associated antigens in culture medium of malignant melanoma cell strains. Cancer Immunol Immunother 1979; 7: 59-64.
24. 24. Berthier-Vergnes O, Portoukalian J, Doré JF. Organization and neuraminidase susceptibility of sialic acid residues in human melanoma cell lines with different heterotransplantabilities in nude mice. J Natl Cancer Inst 1985; 75: 605-11.
25. 25. Jacubovich R, Cabrillat H, Gerlier D et al. Tumorigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumor mechanism. Br J Cancer 1985; 51: 335-45.
26. 26. Bailly M, Bertrand S, Doré JF. Human tumor spontaneous metastasis in immunosuppressed newborn rats. I. Characterization of the bioassay. Int J Cancer 1991; 49: 457-66.
27. 27. Polette M, Gilles C, De Bentzmann S et al. Association of fibroblastoid features wilh the invasive phenotype in human bronchial cancer cell lines. Clin Exp Metastasis 1998; 16: 105-112.
28. 28. Montgomery AMP, De Clerck YA, Langley KE et al. Melanoma mediated dissolution of extracellular matrix: Contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res 1993; 53: 693-700.
29. 29. MacDougall JR, Bani MR, Lin Y et al. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 1995; 55: 4174-81.
30. 30. Kolkenbrockk H, Hecker-Kia A, Orgel D et al. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol Chem 1997; 378: 71-6.
31. 31. Höyhtyä M, Hujanen E, Turpeenniemi-Hujanen T, et al. Modulation of type IV collagenase activity and invasive behavior of metastatic human melanoma (A20T8) cells in vitro by monoclonal antibodies to type IV collagenase. Int J Cancer 1990; 46: 282-6.
32. 32. Hujanen ES, Turpeenniemi-Hujanen T. Recombinant interferon alpha and gamma modulate the invasive potential of human melanoma in vitro. Int J Cancer 1991; 47: 576-81.
33. 33. Väisänen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumor progression and may have prognostic value. J Pathol 1996; 180: 283-9.
34. 34. Varachaud A, Berthier-Vergnes O, Rigaud M et al. Variable expression of Mn SOD in three different human melanoma cell lines. Eur J Dermatol 1998; 8:90-4.
35. 35. Seiki M. Membrane-type matrix metalloproteinases. APMIS 1999; 107: 137-43.
36. 36. Pyke C, Ralfkiaer E, Huhtala P. et al. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992; 52: 1336-41.
37. 37. Borchers AH, Sanders LA, Powell MB, Bowden GT. Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells. Exp Cell Res 1997; 231: 61-65.
38. 38. Liotta LA. Tumor invasion and metastases-Role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986; 46: 1-7.
39. 39. Haas TL, Davis SJ, Madri JA. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 1998; 273: 3604-10.
40. 40. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1998; 58: 3743-50.
41. 41. Ellerbroek SM, Fishman DA, Kerns AS et al. Ovarian carcinoma regulation of matrix metalloproteinases-2 and membrane type 1 matrix metalloproteinase throgh β1 integrin. Cancer Res 1999; 59: 1635-41.